The pharmacokinetics of equoral versus neoral in stable renal transplant patients: A multinational multicenter study

Transplantation Proceedings

Volumn 36, Issue 1, 2004, Pages 80-83

  Masri, M A ^a   Haberal, M ^b   Rizvi, A ^b   Stephan, A ^b   Bilgin, N ^b   Naqvi, A ^b   Barbari, A ^b   Kamel, G ^b   Zafar, N ^b   Emiroglu R ^b   Colak T ^b   Manzoor, K ^b   Matha, V ^b   Kamarad, V ^b   Rizk, S ^b   Itany, A R ^b   Shehedeh, I ^b  

^a RIZK HOSPITAL   (Lebanon)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

AREA UNDER THE CURVE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG URINE LEVEL; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SIDE EFFECT;

EID: 10744230151     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.11.007     Document Type: Conference Paper

References (9)

1. Stephan A.G., Barbari A., Masri M.A., et al. Evaluation of the new cyclosporine formulation, Consupren, in renal transplant patients. Transplant Proc. 28:1996;1348.
2. Masri M.A., Barbari A., Stephan A., et al. Cyclosporine pharmacokinetics in stable renal transplant patients effect of formulation Sandimmun versus Consupren versus Neoral . Transplant Proc. 28:1996;1318.
3. Kamel G., Stephan A., Masri M.A., et al. Donor-specific transfusion under the new cyclosporine A formulation Consupren versus azathioprine, Imuran. Transplant Proc. 29:1997;2960.
4. Stephan A., Masri M.A., Barbari A., et al. A one-year comparative study of Neoral vs Consupren in de novo renal transplant patients. Transplant Proc. 30:1998;3533.
5. Barbari A., Stephan A., Kamel G., et al. Experience with new cyclosporine formulations: Consupren and Neoral in renal transplant patients. Transplant Proc. 29:1997;2941.
6. Masri M.A., Barbari A., Stephan A., et al. Safe and cost effective conversion from Neoral to Consupren soft gelatin capsules in stable renal transplant patients a 1-year study . Transplant Proc. 31:1999;3302.
7. Masri M.A., Stephan A., Barbari A., et al. Cyclosporine formulations is there really a difference? Transplant Proc. 32:2000;1468.
8. Masri M.A. The generics in transplantation and rules on their use. Experimental and Clinical Transplantation. 1:2003;65.
9. Andrysek T., Masri M., Jegorov A., et al. Equoral, new cyclosporine drug delivery system, versus neoral a bioequivalence study in healthy volunteers . Transplant Proc. 35:2003;203.